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Abstract: Background: There is increasing interest in deploying screening, brief intervention, and
referral to treatment (SBIRT) practices in emergency departments (ED) to intervene
with patients at risk for substance use disorders (SUD). However, the current literature
is inconclusive on whether SBIRT practices are effective in reducing costs and
utilization.
Objective: This study sought to evaluate the healthcare costs and healthcare utilization
associated with SBIRT services in the ED.
Research Design: This study analyzed downstream healthcare utilization and costs for
patients who were exposed to SBIRT services within an Allegheny County,
Pennsylvania, ED through a program titled Safe Landing compared to 3 control groups
of ED patients (intervention hospital pre-intervention, and pre- and post-intervention
time period at a comparable, non-intervention hospital).
Subjects: The subjects were patients who received ED SBIRT services from January 1
to December 31 in 2012 as part of the Safe Landing program. One control group
received ED services at the same hospital during a previous year. Two other control
groups were patients who received ED services at another comparable hospital.
Measures: Measures include total healthcare costs, 30-day ED visits, 1-year ED visits,
inpatient claims, and behavioral health claims.
Powered by Editorial Manager® and ProduXion Manager® from Aries Systems Corporation
Results: Results found that patients who received SBIRT services experienced a 21%
reduction in healthcare costs and a significant reduction in 1-year ED visits (decrease
of 3.3 percentage points).
Conclusions: This study provides further support that SBIRT programs are cost-
effective and cost-beneficial approaches to SUD management, important factors as
policy advocates continue to disseminate SBIRT practices throughout the healthcare
system.
Keywords: screening, brief intervention, and referral to treatment; overdose;
emergency department; healthcare costs; and utilization.
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Reviewer Comment Revision/Response 
Editor 
Please find the comments of the reviewers below. We would be 
willing to reconsider this manuscript pending a satisfactory revision 
and response to the reviewers' comments and critiques. 
Thank you for the comment. The authors believe 
they have sufficiently responded to the reviewers’ 
comments and critiques. Please see below our 
point-by-point response.   
This is a request for a major revision. At this point, clearly, we 
cannot promise eventual publication. 
Thank you for the comment. The authors 
understand that this is a major revision. The 
authors believe they have sufficiently responded 
to the reviewers’ comments and critiques. Please 
see below our point-by-point response.   
Reviewer 1 
This manuscript makes an important addition to the literature on 
the relationship between SBIRT intervention and utilization and 
cost. The paper is well written and the statistical analysis is 
generally appropriate. A few clarifications would enhance the paper. 
Thank you for the comments. No revision needed.  
The author(s) mention the use of two different control hospitals 
which are similar. Were they similar programmatically (e.g. size, 
case mix)? Or were the comparison metrics those mentioned in 
Table 1? 
Thank you for the comment. Yes, the comparison 
metrics were those mentioned in Table 1. They 
include: demographics (age, gender, and race), 
number of claims, and total costs.  The authors 
have added additional details about the hospitals 
in the methods section, paragraph 1.  
P-values for Table 1 need to be added. 
Thank you for the comment. P-values have been 
added to Table 1.  
It is still unclear why the same control hospital could not be used to 
assess time-trend as well as intervention/control effect. 
Thank you for the comment. There is only one 
control hospital within our study. There are two 
subgroups within the single control hospital: 
patients who received ED services at the hospital 
during 2010 and patients who received ED 
services during 2012. This study design controls 
for the time-trend effect as well as the 
intervention-control effect.  
Response to Reviewers
2 
The use of DnDnD is relatively new in this field. It would be helpful 
to the readers to walk through the model equation and the 
parameter interpretation in a little more detail. 
Thank you for the comment. The model equation 
has been added to the text, along with descriptions 
of the model parameters. 
The use of linear probability model instead of the usual logistic 
regression needs to be justified. There are reasons to use either in 
given situations but it is not obvious why the author(s) would 
choose the linear probability model for utilization in this case. 
Thank you for the comment. A mixed effects linear 
model was used so that it was easier to interpret 
interactions within the model. Justification has 
been added within the text. 
It seems from Table 2 that the pre-index costs were lower in year 
2012 even in the intervention hospital compared to 2010. Any 
reason why? How does that affect the interpretation of decreased 
cost post-index? 
Thank you for the comment. The authors have 
though about this comment and believe the affect 
could be due to the passing of the Affordable Care 
Act – signed into law in 2010. 
 
Regardless, the lower pre-index costs doesn’t 
affect the interpretation; the authors explicitly 
controlled for time within the model, so the main 
effect picks up that difference within the model. 
As mentioned earlier, it is unclear whether the DnDnD model 
controls for this trend. It would be helpful to see the model equation 
written out. 
As addressed in the comment above, there is only 
one control hospital within the study, and the 
model does control for the time trend. The model 
equation and a further description of the variables 
within the model has been added to the text. 
In the discussion section, the authors need to soften the language re: 
causality. 
Thank you for the comment. The authors have 
hedged the language a bit in the discussion.  
Table 2, lines between average costs and standard error can be 
removed as it is too busy to read. 
Thank you for the comment. This has been 
completed. This change was also made to Table 1 
and 3, where appropriate.  
"The results of analyses conducted with Allegheny County service 
data indicated an average of 6 to 14 ED visits were related to 
overdose and persons…."Should these be percentages? 
Thank you for the comment. No, these are not 
percentages; they are the average number of ED 
visits related to overdose per day. This has been 
revised to be clarified.  
 
This statistic was acquired from the following 
reference: 
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Hulsey E, Brink L, Dalton E, et al. Opiate-Related 
Overdose Deaths in Allegheny County: Risks and 
Opportunities for Intervention. 2016. 
If the above clarifications require additional space, the SBIRT 
training and fidelity section could be tightened a little. 
Thank you for the comment. The authors have 
removed a lot of the content on SBIRT training and 
fidelity. The authors also removed additional 
results on SBIRT numbers.  
Reviewer 2 
This was an excellent study design describing the cost effectiveness 
of healthcare utilization and health care costs, as measured by 
Medicaid claims data, associated with care after SBIRT was 
implemented in one Pennsylvania Hospital with three sets of 
controls: a historical control, and two contemporaneous controls 
(other hospitals). 
Thank you for the comment.  
A recent review suggests efforts to reduce emergency department 
visits are sparse - I wonder if the authors feel comfortable extending 
their findings to this line of inquiry. See: Raven MC, Kushel M, Ko MJ, 
et al. The effectiveness of emergency department visit reduction 
programs: a systematic review. Annals of Emergency Medicine. 
2016;68(4):467-483 e415. 
Thank you for the comment. The authors added a 
sentence and this citation to a paragraph in the 
discussion about studies implementing 
interventions in the real world.  
More details could be provided about the weighted propensity score 
and associated diagnostics. I assume an ATT model was used. 
Thank you for the comment. Clarification has been 
added.  
What variables were included in the modeling? 
Thank you for the comment. The model equation 
has been added to the text, which shows the 
variables utilized in the modeling. Additional 
descriptions of the variables were also added 
within the text following the model equation. 
Did all [variables] achieve reasonable balance post-weighting? 
Thank you for the comment. Yes, all variables 
achieved a reasonable post-weighting balance. 
These are unadjusted means, demonstrates the 
need for the PS match. Added to footnote to clarify. 
By what threshold? If not, were doubly-robust statistical models 
used? 
Thank you for the comment. Standardized 
differences between the pre-weighted and post-
weighted variables were calculated, and the 
average difference was added to the text. They 
achieved a reasonable standardized difference 
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based on the threshold in the study cited within 
the text (Austin PC). 
The paragraph on page 15 beginning with "Additionally, Safe 
Landing…" seems to present results from a separate paper, but it is 
not clear to me how that other paper justifies the statement that it 
follows. 
Thank you for the comment. The authors removed 
the paragraph as we removed the content in the 
methods broaching this topic. 
Furthermore, that paragraph provides new results regarding the 
implementation of the intervention in the hospital, but those results 
are not presented in the paper. I recommend either providing 
specific citations for this intervention, or to consider dropping this 
paragraph and including summaries specific to the results presented 
here. 
Thank you for the comment. The authors removed 
the paragraph as we removed the content in the 
methods broaching this topic. 
I appreciate that the results for Tables 2 and 3 distinguish between 
the different control groups, but Table 1 does not. I do not 
understand why all control hospitals are lumped together - they 
should be separated. Also, differences between the groups should be 
easier to see (i.e., indicators of p<0.05, as done in Tables 2 and 3). 
Thank you for the comment. As was clarified 
before, there is only one control hospital within 
our study. Table 1 distinguishes between the two 
subgroups within the control hospital (years 2010 
and 2012). P-values have been added to the table. 
I would like to see Tables that provide the full set of results from the 
weighted regression models. It's not intuitively apparent to me how 
the regression results are used to calculate the values produced in 
Tables 2 and 3. These tables just show that costs 
decreased/increased within hospitals, but the regression results 
should show that such changes (i.e., the 21% reduction in the 
intervention hospital) are greater than the 6.2% reduction in 
intervention hospital, 2012. This isn't really apparent from the 
tables. Further, such results should be described more fully in the 
paper. 
Thank you for the comment. The results have been 
restructured; Table 2 now shows the full 
regression results, and Table 3 shows the model 
estimates from the regression results. 
Reviewer 3 
The study design remains somehow unclear. The focus of the study 
clearly is set on costs and healthcare utilization. The study design is 
a sort of cost-minimization analysis, comparing the costs without 
taking the patient-relevant outcome gains into consideration. 
Especially in this case in remains unclear how intense and frequent 
the healthcare of these special patients would be adequate. 
Thank you for the comment. Please see how we 
addressed the comments below.  
There is no randomization at all and it remains unclear how the 
study populations where selected. 
Thank you for the comment. Our study was an 
observational study, so therefore we did not use 
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randomization. Clarification has been added to the 
text regarding the study design.  
Please clearly describe the study design and methods in health 
economic wording 
Thank you for the comment. Language has been 
adjusted.  
The costing process remains completely unclear. What is the 
perspective? 
Thank you for the comment. The cost of the 
intervention was not the focus of this study; the 
focus was on the healthcare cost and utilization 
impact of SBIRT. A future study could focus on 
costing the intervention and examine how cost 
effective an SBIRT program actually is; a 
paragraph about this has been added to the 
discussion section. 
What data is used and where do the information come from? 
Thank you for the comment. The data extraction 
process and the specific data that was obtained 
have been clarified within the text. 
Are all costs taken into consideration covered by Medicaid? 
Thank you for the comment. Yes. A sentence has 
been added for clarification in the Healthcare Costs 
subsection.  
What about out-of-pocket costs? 
Thank you for the comment. Out-of-pocket costs 
and payment by other payers are not included. 
Clarified in the Healthcare Costs subsection. 
What are the costs of the special program itself? 
Thank you for the comment. The cost of the 
intervention was not the focus of this study; the 
focus was on the healthcare cost and utilization 
impact of SBIRT. A future study could focus on 
costing the intervention and examine how cost 
effective an SBIRT program actually is; a 
paragraph about this has been added to the 
discussion section. 
It would be great to see details of resource utilization such as 
inpatient, outpatient, pharmaceuticals, psychological treatment etc. 
if available. 
Thank you for the comment. Additional detail 
regarding resource utilization has been added to 
Table 1. 
From my point of view there are too many methodological issues 
unsolved (or at least unclear) to be able to assess the validity of the 
results. In comparison to the method descriptions the description of 
Thank you for the comment. The authors have 
removed a lot of the description of the 
intervention and added more to the methods. We 
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the intervention is too long. Therefore I recommend full revision 
and resubmission. 
hope this clarifies and details the mentioned 
methodological issues.  
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Background: There is increasing interest in deploying screening, brief intervention, and referral 
to treatment (SBIRT) practices in emergency departments (ED) to intervene with patients at risk 
for substance use disorders (SUD). However, the current literature is inconclusive on whether 
SBIRT practices are effective in reducing costs and utilization.  
Objective: This study sought to evaluate the healthcare costs and healthcare utilization 
associated with SBIRT services in the ED. 
Research Design: This study analyzed downstream healthcare utilization and costs for patients 
who were exposed to SBIRT services within an Allegheny County, Pennsylvania, ED through a 
program titled Safe Landing compared to 3 control groups of ED patients (intervention hospital 
pre-intervention, and pre- and post-intervention time period at a comparable, non-intervention 
hospital).  
Subjects: The subjects were patients who received ED SBIRT services from January 1 to 
December 31 in 2012 as part of the Safe Landing program. One control group received ED 
services at the same hospital during a previous year. Two other control groups were patients who 
received ED services at another comparable hospital. 
Measures: Measures include total healthcare costs, 30-day ED visits, 1-year ED visits, inpatient 
claims, and behavioral health claims. 
Results: Results found that patients who received SBIRT services experienced a 21% reduction 
in healthcare costs and a significant reduction in 1-year ED visits (decrease of 3.3 percentage 
points).  
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Conclusions: This study provides further support that SBIRT programs are cost-effective and 
cost-beneficial approaches to SUD management, important factors as policy advocates continue 
to disseminate SBIRT practices throughout the healthcare system.  
Keywords: screening, brief intervention, and referral to treatment; overdose; emergency 
















 Substance use disorders (SUD) and harmful drug and alcohol use are increasing problems 
in the United States.1 Opioid overdoses have been declared a nationwide epidemic, with more 
than 28,000 opioid-related deaths in 2014.2 In addition to the individual and population health 
risks, patients with SUDs and those who engage in harmful drug and alcohol use also pose a 
significant toll on healthcare utilization for the healthcare system.3 
 Screening, brief intervention, and referral to treatment (SBIRT) is an evidence-based 
approach for identifying and intervening with individuals who misuse alcohol or other drugs.4 
SBIRT uses a validated screening procedure to classify at-risk patients into risk categories.5 
Those at moderate risk of harm from their substance misuse receive a brief intervention (BI), a 
short conversation using motivational interviewing principles to encourage behavior change, 
while those at higher risk are referred to appropriate care.5,6 
 Policy advocates contend that SBIRT is cost-effective and cost-beneficial.7,8 However, 
the evidence supporting these conclusions is limited and primarily focused on alcohol screening 
and brief intervention (SBI) within primary care settings.7-10 In a 2009 review, Latimer et al. 
concluded that cost-effectiveness evidence for alcohol SBI is scarce, and it is unclear whether 
SBI for alcohol misuse results in net cost savings.9 Bray et al. found little evidence that alcohol 
SBI would reduce downstream healthcare use and costs after reviewing the literature from 1962 
to 2010.11 
 However, some studies suggest that SBIRT may be cost-effective and cost-beneficial, 
specifically in emergency department (ED) settings. A quasi-experimental study by Estee et al. 
resulted in significant Medicaid savings associated with SBIRT when it was implemented in EDs 
in Washington state.12 Additionally, Barbosa et al. found that SBIRT services cost $8.63 less in 
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ED settings compared to outpatient settings and resulted in 13.7% more patients drinking below 
threshold levels.13 A study conducted by Gentilello et al. also suggested that SBIRT applications 
within an ED result in a subsequent reduction in ED readmissions up to 36 months after the 
interventions.14  
The Pennsylvania Department of Human Services (DHS) studied the costs of care in 
different healthcare settings for Medicaid patients. ED visits and repeated admissions to hospitals 
were identified as some of the highest cost drivers.15 Moreover, a significant proportion of the 
patients receiving Medicaid who were high ED and hospital utilizers also had diagnoses of SUD. 
Thus, the Pennsylvania Department of Human Services’ Medicaid Office sought to apply ED-
based interventions that could reduce downstream costs (largely mediated via reduced ED visits 
and hospital readmissions). Given the ED-associated SBIRT research and DHS’ need to find a 
way to reduce ED and hospital admissions among its Medicaid patients, the program titled Safe 
Landing was developed, which implemented SBIRT services within 1 ED in Allegheny County, 
Pennsylvania. 
 The aims of the Safe Landing program and this study were two-fold: (1) determine 
whether the implementation of the ED SBIRT services resulted in significantly reduced 
downstream healthcare costs; and (2) determine whether the implementation of the ED SBIRT 
services resulted in significantly reduced patient ED visits. 
Methods 
Study Setting and Intervention 
This study was a retrospective analysis of a quality assurance intervention, in which the 
project team compared a group of adult patients who received ED SBIRT services from January 
1 to December 31 in 2012 from the intervention hospital where Safe Landing was implemented 
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against 3 groups of ED patients who did not receive SBIRT services. One control group 
consisted of patients who received ED services at the intervention hospital in 2010 (prior to 
implementation of Safe Landing). The other 2 control groups included patients who received ED 
services at a different, but comparable, hospital in 2010 and 2012, respectively. This design 
controlled for time trend effects (e.g., state-wide policy changes) and hospital effects (i.e., 
intervention hospital vs. control hospital). The 2 hospitals were programmatically similar and 
compared based on patient demographics (age, race, and gender), number of claims, and 
total healthcare costs (see Table 1). Both hospitals are located in Pittsburgh’s metropolitan 
area, and each of the hospitals is a part of 1 of the 2 largest health systems. The study team 
received Institutional Review Board exemption to conduct this study. 
 The Safe Landing intervention involved several systematic steps for each patient. First, 
the patient was asked validated questions concerning their substance use (“triage-screen” or “pre-
screen”) by the triage nurse.16 The “triage screen” was embedded into the intervention hospital’s 
electronic health record (EHR). If the patient’s answers indicated the patient was at risk for 
overdose, then additional screening questions were asked by the treatment nurse using the 
evidence-based Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST) 
screening instrument (“screen”).17 Next, numerical values tallied from the patient’s ASSIST 
responses were used to calculate a “risk score” in an automated fashion in the EHR system of the 
intervention hospital (with levels being: no risk, low risk, moderate, high, and significant). Based 
on the patient’s ASSIST score, the patient received brief feedback (no-/low-risk) or a BI 
(moderate risk) from the treatment nurse.  
 Patients scoring with high or significant ASSIST risk levels were identified for referral to 
SUD treatment and received a BI intended to boost patients’ commitment to accept a referral and 
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immediately pursue rehabilitation and recovery services upon discharge. When these high-risk 
patients expressed a willingness to seek specialty treatment, the intervention site ED staff (nurses 
and social workers) facilitated access to specialty treatment and services via a “warm hand-off” - 
the process of introducing the patient to the behavioral health provider in real time. The BIs and 
referrals to SUD treatment were noted in a designated part of the EHR using the Healthcare 
Common Procedure Coding System (HCPCS) associated with SBIRT services.18 
 Trained ED staff conducted the interventions. Training consisted of 3 hour-long didactic 
lecture modules held at various time points beginning in May 2010 and concluding in June 2011. 
Four sessions were held for each module to capture the entire ED staff. The first module trained 
ED staff on addiction and overdose, specifically the scope of the problem in the intervention 
ED’s catchment area, and an introduction to SBIRT. The second module trained ED staff on how 
to conduct screenings, assess patient risk level, and conduct BIs using motivational interviewing 
techniques.19,20,21 The third module trained ED staff on referral to treatment and proper protocols 
for completing “warm hand-offs” of patients to recovery supports and treatment. Several booster 
sessions were provided upon the health system’s request to reinforce concepts covered in the 
curriculum and ensure continued program fidelity. New staff received training on all modules as 
they were hired.  
Subjects, Data, and Measures 
 Eligible patients included those who had visited 1 of the hospitals’ EDs during either 
2010 or 2012 and had Medicaid coverage; they were identified by an honest broker (HB). The 
experimental group from the intervention hospital in 2012 consisted of 2,546 patients, and the 
control group from the intervention hospital in 2010 consisted of 2,817 patients. The control 
group from the control hospital in 2012 consisted of 3,678 patients, and the control group from 
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the control hospital in 2010 consisted of 3,112 patients. The study was designed as 
observational, where patients who had claims within the specified timeframes comprised 
the groups of the study. Random assignment to different treatments was not used. All 
patients who required brief feedback or a brief intervention received this step of the 
intervention at the intervention hospital, if desired.  
 The data comprised Medicaid healthcare claims from 2010 and 2012 for all study 
subjects. The HB extracted the claims data for all patients who visited 1 of the hospitals during 
the years of interest. Each patient was assigned an index ED date, which signifies the first ED 
visit date of the year for each year. All claims data for these patients for the 12 months preceding 
and 12 months following the index ED visit were extracted and analyzed. 
 Healthcare Costs. Total healthcare costs were estimated by summing all allowable 
charges within general and behavioral health data, excluding the index ED event. Out-of-pocket 
costs and payment by other payers were not included within the total healthcare cost 
calculations, and all costs taken into consideration were covered by Medicaid. 
Healthcare Utilization. Binary measures were generated for ED visits within 30 days and 
1 year of the index event, inpatient claims, and outpatient behavioral health claims where 0 
indicated no claim and 1 indicated at least 1 claim in the associated time period before or after 
the index ED event. Control variables also provided by the HB included patient demographics 
(age, gender, and race/ethnicity) and the number of months the patient was covered by Medicaid. 
Statistical Analyses 
 Dependent variables were constructed comprising aggregate measures for a patient 
within the study time period for each of the outcome measures. Multilevel models with 
individual random effects were estimated using patient demographics and lengths of 
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coverage as controls. The independent variables of interest were an indicator of the index 
event provider (intervention or control hospital), year of the index event (2010 or 2012), 
and a pre- or post-index event indicator designating the 12 months before the index ED 
visit versus the 12 months after. Interacting these variables in the model produces a 
Differences in Differences in Differences (DnDnD) design.20,21  
 To assess the healthcare cost effects of the Safe Landing intervention, healthcare 
costs were modeled using a multilevel generalized linear model (GLM) assuming a gamma-
distributed dependent variable and a log link function. Gamma GLM is often used to 
model cost data because of the common positive skew in the data.22,23 Healthcare events 
(i.e., 30-day ED use, 1-year ED use, inpatient claims, and outpatient behavioral health 
claims) were modeled using multilevel linear probability models. A linear probability 
model was estimated not only due to ease of interpretation, but also because equivalently 
specified propensity score weighted nonlinear models were unable to converge. In addition, 
it has been shown that the use of the linear probability model is suitable in the case where 
the means of the dependent variables are not close to 0 or 1, as it is in this case.24  
The DnDnD models are specified as follows: 
Yit = f(β0 + β1HOSPi + β2POSTit + β3YEARi + β4HOSPi*POSTit + β5HOSPi*YEARi + 
β6POSTit*YEARi + β7HOSPi*POSTit*YEARi + β8Xit + γGi) + εit 
 Yit is the outcome for person i at time t, f(∙) is a link function (log for the cost models 
and identity link for the utilization outcomes), and εit is an independent and identically 
distributed (IID) error or residual. Specifying both f(∙) and the distribution of εit yielded 
various models appropriate for a variety of outcomes. The βs are fixed-effect parameters to 
be estimated, and γ is a vector of random-effect parameters (i.e., variance components) to 
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be estimated. HOSP is a dichotomous variable set to 1 when the individual had his/her 
index ED event at the intervention hospital and 0 otherwise. POST is a dichotomous 
variable set to 1 for observations corresponding to the year following the index visit and 0 
otherwise. YEAR is a dichotomous variable set to 1 if the individual’s index event occurred 
in 2012, and 0 otherwise. The next 4 items are interaction terms of the preceding 3, and Xit 
is a vector of demographic characteristics (i.e., age, gender, and race/ethnicity) and 
adjustments for partial year follow-up (due to lack of Medicaid coverage through the year). 
Gi is a vector of indicator variables for each included patient. β7 captures the change in the 
outcome for those receiving the index ED event at the intervention hospital when SBIRT 
was intended to have been delivered relative to the comparison group. Thus, this captured 
the association between an intention of SBIRT delivery and healthcare utilization and cost 
outcomes. 
 To minimize the impact of observable confounders, a propensity score was 
estimated and represented the likelihood that each included patient would be in the 
treatment group.25 The propensity score was derived from a logit regression of treatment 
group membership on demographics and pre-index event costs and utilization. Kernel 
matching was used to weight all patients in the comparison groups such that the 
comparison groups resembled the treatment group in terms of the potential confounding 
variables. Weights applied to control group members are a function of the distance 
between their propensity score and those of treated subjects, thus providing for estimates 
representing the average treatment effect on the treated subjects. Following the application 
of propensity score weights, standardized differences indicated that the treatment and 
control groups were sufficiently balanced, as no covariate had a weighted standardized 
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difference exceeding 0.1.20 The average standardized difference following the application of 
the weights was 0.016. 
Results 
 Table 1 shows the patient characteristics for the intervention and control groups. Typical 
subjects were in their late 20s or early 30s. Subjects were predominantly White and African-
American females. Subjects were covered by Medicaid between 8 and 11 months out of a 
possible 13 months on average. There are 13 months total because the month of the index event 
and the preceding 12 months were included. Patients had between 110 and 124 claims in the year 
before the index event and between 94 and 160 claims in the year after the index event on 
average. 
Table 1. Characteristics of Study Sample by Index Event Year and Index Event Provider 
(Intervention vs. Control Hospital) 
Table 2 below shows the full specification of the regression models, with coefficient 
and interaction estimates. The first row of the table contains the triple interaction, which 
represents the effect of the interaction net of hospital, year, and time (pre/post) effects. 
Model output shows a significant negative association between the intervention group and 
total costs (p<0.001), ED claims after 1 year (p<0.01), inpatient claims after 1 year (p<0.01), 
and behavioral health claims after 1 year (p<0.05).  
Table 2. Full Model Outputs of Healthcare Costs and Utilization 
Table 3 below details the model predictions from the models shown in Table 2, along 
with significance tests between the intervention group and the other groups of the study. 
The model estimates show the magnitude of the changes for the various model effects. 
Overall, total healthcare costs declined by 21% for the intervention group (($9,954 - 
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$7,880)/$9,954) in the 12 months following the index event relative to the 12 months prior. 
The incidence of ED visits and inpatient claims also fell significantly in the intervention 
group (3.3 and 4.1 percentage points, respectively).  
Table 3. Estimates of Impacts of SBIRT on Healthcare Costs and Utilization 
Discussion 
Potential Effects on Healthcare Costs and Public Policy 
 This project has several salient considerations regarding how to address SUDs. SUDs can 
lead to increased healthcare utilization and costs,3 and this study suggests that SBIRT programs 
may have the potential to improve patient outcomes via reductions in healthcare utilization, and 
resultant decreased costs.  
 The current study found that the implementation of an ED-based SBIRT program was 
associated with 21% lower healthcare costs from pre-index event to post-index event. This 
translates to approximately $2,100 per patient per year. This reduction in healthcare costs could 
be linked mainly to decreased inpatient use, which accounted for approximately 72% of the 
change in costs in the SBIRT group. Complementing this overall decrease in inpatient costs, 
there was also a statistically significant reduction in 1-year ED visit rates. Additionally, there 
was a moderate effect on the use of behavioral healthcare, which also contributed to a small 
portion of the decrease in costs. However, as a sensitivity analysis, models were estimated using 
only healthcare costs that were unrelated to behavioral healthcare; the reduction in behavioral 
healthcare costs in these models is virtually unchanged.  
 There are a number of possible explanations for the association with lower costs. First, 
Safe Landing may have prevented patient relapses requiring detoxification and associated acute 
treatment. A decrease in patient relapses means the costs necessary for these patients and visits 
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would be negated. Second, BIs may have prevented the need for more intensive treatment, 
reducing the number of referrals to more expensive treatment services, and thus reducing overall 
costs at this level. Third, through patient awareness, the triage screening may have had an impact 
upon patient alcohol and drug use by patients. Finally, it is possible that some reductions are 
because of improvements in general health and a reduction in accidents associated with 
decreased substance use. These are just a few interpretations, but future research on the types of 
inpatient and behavioral healthcare patients receive is needed to understand the types of patients 
and care possibly influenced by SBIRT.  
 The SBIRT Safe Landing program makes an important contribution to the literature on 
the impact of SBIRT implemented in real-world settings rather than traditional randomized 
clinical trials. Few studies have rigorously analyzed the potential reduction in healthcare costs 
associated with SBIRT. Even fewer studies are set in the ED and focused on the potential to 
reduce ED visits.26 A challenge to estimating the impact of SBIRT on healthcare costs in a real-
world setting is a lack of adequate control groups because it is often not feasible to generate such 
a sample by design. However, Estee et al. used a control group of patients drawn from Medicaid 
claims data and propensity scores matched to SBIRT patients and concluded that SBIRT did 
reduce healthcare costs.12 Our project also used claims data and propensity score matching, but 
across 3 different control groups, allowing for time and setting factors to be accounted. As 
Raven et al., note, it is essential that future studies remain rigorous when studying 
interventions in the ED so that more definitive results can be made about intervention 
effectiveness for improving patient care or reducing healthcare costs.26 
 A plausible next step of the Safe Landing program, and therefore a focus of a future 
study, would be to consider the cost of the intervention and determine its cost-effectiveness. 
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The focus of the current study was on the impact of SBIRT on healthcare costs and 
healthcare utilization. However, a future study could examine the cost savings of an SBIRT 
intervention in terms of healthcare utilization versus the cost of delivering SBIRT. A study 
of this nature would provide valuable insight into the true cost-effectiveness of SBIRT 
services, and in particular, ED-based SBIRT services.   
 Finally, besides potentially attenuating downstream healthcare costs, the application of 
SBIRT within the ED could provide a significant strategy communities can use to reduce 
overdose risk.27 The results of analyses conducted with Allegheny County service data indicated 
an average of 6 to 14 ED visits per day were related to overdose, and persons who died from 
overdose had touched an ED at least once in the year prior to their death.28 The impact of 
providing SBIRT services within community EDs on subsequent overdose risk is worthy of 
future study and could provide further support for implementing SBIRT in this healthcare 
setting.  
Conclusion 
 In this study, SBIRT implementation showed the potential to reduce healthcare 
costs and utilization as measured by Medicaid claims data. As the United States healthcare 
system moves toward reducing healthcare costs while also improving patient health, it will be 
important to provide evidence that new and existing methods can achieve these goals.29 SBIRT 
use in the ED has the potential to achieve these objectives in a manner that can be readily 
incorporated into existing practice settings. 
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Authors’ analysis of data from the Safe Landing project. Statistics are unadjusted (i.e., propensity score 
weights are not applied) 
Patient data ranges from 2009-2013. 
SD = Standard deviations in parentheses.  
Specialty alcohol/drug treatment claims and detox claims identified using procedure codes/modifiers. 
Behavioral health events identified by source of claim. 
Patients were drawn from 2 hospitals based on whether they had an ED visit in 2010 or 2012. 
ED = emergency department 
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Observations  24300 24,300 24,300 24,300 24,300 







costs in 1 
year 
Any ED 
Claim in 30 
days 
Any ED 










claim in 1 
year 
SE = Standard errors in parentheses. 
Cost modeled as mixed effect gamma GLM; binary outcomes modeled as mixed effects linear models.  
Data from patients who visited either intervention hospital or control hospital in 2010 and/or 2012. Patients 
with index events in both years are considered to be separate for the purpose of these models. 




































































































































- $7,880 25.4% 57.3% 14.2% 37.7% 
Authors’ analysis of data from the Safe Landing project.  
Data ranges from 2009-2013. 
ED = emergency department 
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